Jefferies lowered the firm’s price target on Comerica to $58 from $62 and keeps a Buy rating on the shares. Comerica is optimistic on NII in 2025 and beyond given swaps and securities maturities and loan growth, but lower-than-expected direct debit authorizations has weighed on near-term NII results, the analyst tells investors in a research note. Management will look to offset rising regulatory prep costs over time through efficiency gains, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA:
